Pure Global AI
ANVISA registration 81077790013Valid until Apr 30, 2028

ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)

ANVISA Registration Number: 81077790013REM INDUSTRIA E COMERCIO SOCIEDADE UNIPESSOAL LTDAREM INDUSTRIA E COMERCIO SOCIEDADE UNIPESSOAL LTDARisk Class IV
Device names
Technical name
ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
PT: ANTICORPO PARA VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 E TIPO 2 (HIV 1 E HIV 2)
Commercial name
GOLD RAPID TEST HIV ½
Risk class
Class IV
Registration details
Registration Number
81077790013
Process Number
25351490846201727
CNPJ
47334701000635
Company information
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Apr 30, 2018
Validity
30/04/2028
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81077790013 and manufactured by REM INDUSTRIA E COMERCIO SOCIEDADE UNIPESSOAL LTDA. The registration is held by REM INDUSTRIA E COMERCIO SOCIEDADE UNIPESSOAL LTDA with validity until Apr 30, 2028.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.